JP2007517016A - 低溶解性薬剤及びポロキサマーの固体組成物 - Google Patents
低溶解性薬剤及びポロキサマーの固体組成物 Download PDFInfo
- Publication number
- JP2007517016A JP2007517016A JP2006546397A JP2006546397A JP2007517016A JP 2007517016 A JP2007517016 A JP 2007517016A JP 2006546397 A JP2006546397 A JP 2006546397A JP 2006546397 A JP2006546397 A JP 2006546397A JP 2007517016 A JP2007517016 A JP 2007517016A
- Authority
- JP
- Japan
- Prior art keywords
- drug
- poloxamer
- concentration
- composition
- solid composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53383603P | 2003-12-31 | 2003-12-31 | |
| PCT/IB2004/004287 WO2005065657A2 (en) | 2003-12-31 | 2004-12-20 | Solid compositions of low-solubility drugs and poloxamers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007517016A true JP2007517016A (ja) | 2007-06-28 |
| JP2007517016A5 JP2007517016A5 (cg-RX-API-DMAC7.html) | 2008-02-14 |
Family
ID=34748969
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006546397A Abandoned JP2007517016A (ja) | 2003-12-31 | 2004-12-20 | 低溶解性薬剤及びポロキサマーの固体組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8974823B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1701704A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2007517016A (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0418330A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2548376A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005065657A2 (cg-RX-API-DMAC7.html) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009510138A (ja) * | 2005-10-04 | 2009-03-12 | バイエル・ヘルスケア・アクチェンゲゼルシャフト | 経口投与でき、かつ活性成分の迅速な放出を有する固形医薬投与形態 |
| JP2014500869A (ja) * | 2010-11-09 | 2014-01-16 | エフ.ホフマン−ラ ロシュ アーゲー | Hcv感染症を処置するための医薬組成物 |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2142178B1 (en) * | 2007-03-29 | 2012-01-11 | F. Hoffmann-La Roche AG | Pharmaceutical composition and process |
| HRP20191104T1 (hr) | 2007-09-25 | 2019-09-20 | Solubest Ltd. | Pripravci koji sadrže lipofilne aktivne spojeve i postupak za njihovu pripremu |
| US8889193B2 (en) | 2010-02-25 | 2014-11-18 | The Johns Hopkins University | Sustained delivery of therapeutic agents to an eye compartment |
| SMT202000390T1 (it) * | 2010-07-12 | 2020-09-10 | Salix Pharmaceuticals Inc | Formulazioni di rifaximina e loro usi |
| US20170087134A1 (en) * | 2010-07-12 | 2017-03-30 | Salix Pharmaceuticals, Ltd | Formulations of rifaximin and uses thereof |
| WO2012039979A2 (en) | 2010-09-10 | 2012-03-29 | The Johns Hopkins University | Rapid diffusion of large polymeric nanoparticles in the mammalian brain |
| JP2014532658A (ja) * | 2011-10-28 | 2014-12-08 | セルジーン アヴィロミクス リサーチ, インコーポレイテッド | ブルトン型チロシンキナーゼ疾患または障害を治療する方法 |
| US8962577B2 (en) | 2012-03-16 | 2015-02-24 | The Johns Hopkins University | Controlled release formulations for the delivery of HIF-1 inhibitors |
| CA2867203C (en) | 2012-03-16 | 2016-09-20 | The Johns Hopkins University | Non-linear multiblock copolymer-drug conjugates for the delivery of active agents |
| WO2013166408A1 (en) | 2012-05-03 | 2013-11-07 | Kala Pharmaceuticals, Inc. | Pharmaceutical nanoparticles showing improved mucosal transport |
| CN111700878A (zh) * | 2012-05-03 | 2020-09-25 | 卡拉制药公司 | 显示提高的粘膜转移的药物纳米粒子 |
| US9827191B2 (en) | 2012-05-03 | 2017-11-28 | The Johns Hopkins University | Compositions and methods for ophthalmic and/or other applications |
| US9056057B2 (en) | 2012-05-03 | 2015-06-16 | Kala Pharmaceuticals, Inc. | Nanocrystals, compositions, and methods that aid particle transport in mucus |
| US11596599B2 (en) | 2012-05-03 | 2023-03-07 | The Johns Hopkins University | Compositions and methods for ophthalmic and/or other applications |
| CA2872519C (en) | 2012-05-04 | 2017-09-05 | The Johns Hopkins University | Lipid-based drug carriers for rapid penetration through mucus linings |
| US10568975B2 (en) | 2013-02-05 | 2020-02-25 | The Johns Hopkins University | Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof |
| CN105188371A (zh) | 2013-02-08 | 2015-12-23 | 西建阿维拉米斯研究公司 | Erk抑制剂及其用途 |
| JP5946798B2 (ja) * | 2013-06-18 | 2016-07-06 | 住友ゴム工業株式会社 | タイヤ用ゴム組成物、及び空気入りタイヤ |
| JP5934677B2 (ja) * | 2013-06-18 | 2016-06-15 | 住友ゴム工業株式会社 | タイヤ用ゴム組成物、及び空気入りタイヤ |
| US9492471B2 (en) | 2013-08-27 | 2016-11-15 | Celgene Avilomics Research, Inc. | Methods of treating a disease or disorder associated with Bruton'S Tyrosine Kinase |
| JP6010060B2 (ja) * | 2014-02-21 | 2016-10-19 | 住友ゴム工業株式会社 | タイヤ用ゴム組成物、及び空気入りタイヤ |
| WO2016025561A1 (en) | 2014-08-13 | 2016-02-18 | Celgene Avilomics Research, Inc. | Forms and compositions of an erk inhibitor |
| RU2639819C2 (ru) * | 2014-12-30 | 2017-12-22 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) | Композиция, ингибирующая теломеразу |
| JP6846351B2 (ja) | 2015-01-27 | 2021-03-24 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 粘膜表面における活性薬剤の増強された輸送のための低張ヒドロゲル製剤 |
| CA3038312A1 (en) | 2016-09-30 | 2018-04-05 | Salix Pharmaceuticals, Inc. | Solid dispersion forms of rifaximin |
| WO2020210805A1 (en) | 2019-04-11 | 2020-10-15 | The Johns Hopkins University | Nanoparticles for drug delivery to brain |
| CA3184054A1 (en) | 2020-06-26 | 2021-12-30 | Jacob Cole | Targeted release rifaximin compositions |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE80467B1 (en) | 1995-07-03 | 1998-07-29 | Elan Corp Plc | Controlled release formulations for poorly soluble drugs |
| DK0996429T3 (da) | 1997-10-27 | 2003-05-26 | Merck Patent Gmbh | Faste opløsninger og faste dispersioner i vand tungtopløselige lægemidler |
| AU4797999A (en) | 1998-07-22 | 2000-02-14 | Yamanouchi Pharmaceutical Co., Ltd. | Solid preparation containing sparingly soluble nsaids |
| US6368622B2 (en) | 1999-01-29 | 2002-04-09 | Abbott Laboratories | Process for preparing solid formulations of lipid regulating agents with enhanced dissolution and absorption |
| US6248363B1 (en) | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| US6395300B1 (en) | 1999-05-27 | 2002-05-28 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
| US6264981B1 (en) | 1999-10-27 | 2001-07-24 | Anesta Corporation | Oral transmucosal drug dosage using solid solution |
| EP1175205B1 (en) | 1999-11-12 | 2006-06-14 | Abbott Laboratories | Solid dispersion comprising ritonavir, fenofibrate or griseofulvin |
| WO2001034118A2 (en) | 1999-11-12 | 2001-05-17 | Abbott Laboratories | Solid dispersion pharmaceutical formulations |
| JP2004500358A (ja) | 1999-12-08 | 2004-01-08 | ファルマシア コーポレイション | バイオアベイラビリティーが増加した固体状態のセレコキシブ |
| YU43702A (sh) | 1999-12-23 | 2004-11-25 | Pfizer Products Inc. | Farmaceutske kompozicije koje obezbeđuju povećanje koncentracije leka |
| KR100806412B1 (ko) | 2000-01-28 | 2008-02-21 | 스미스클라인 비참 코포레이션 | 전기방사 약제학적 조성물 |
| AR028253A1 (es) * | 2000-03-16 | 2003-04-30 | Pfizer Prod Inc | Inhibidores de la glucogeno fosforilasa |
| PE20011184A1 (es) * | 2000-03-16 | 2001-11-15 | Pfizer Prod Inc | Composiciones farmaceuticas de inhibidores de la glucogeno-fosforilasa |
| US20010036959A1 (en) | 2000-04-03 | 2001-11-01 | Gabel Rolf Dieter | Carvedilol-hydrophilic solutions |
| AU2001257115B2 (en) | 2000-04-20 | 2005-01-27 | Rtp Pharma Inc. | Improved water-insoluble drug particle process |
| US6316029B1 (en) | 2000-05-18 | 2001-11-13 | Flak Pharma International, Ltd. | Rapidly disintegrating solid oral dosage form |
| GB0015239D0 (en) | 2000-06-21 | 2000-08-16 | Biochemie Gmbh | Organic compounds |
| DE10038571A1 (de) | 2000-08-03 | 2002-02-14 | Knoll Ag | Zusammensetzungen und Dosierungsformen zur Anwendung in der Mundhöhle bei der Bhandlung von Mykosen |
| KR20020014570A (ko) | 2000-08-18 | 2002-02-25 | 김충섭 | 고체분산화시킨 무정형 이프리플라본의 제조방법 |
| CZ20033211A3 (cs) * | 2001-05-03 | 2004-09-15 | F. Hoffmann-La Roche Ag | Farmaceutická léková forma amorfního nelfinavir mesylátu |
| US20030054042A1 (en) * | 2001-09-14 | 2003-03-20 | Elaine Liversidge | Stabilization of chemical compounds using nanoparticulate formulations |
| PL372247A1 (en) * | 2002-02-01 | 2005-07-11 | Pfizer Products Inc. | Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus |
| AU2003214387A1 (en) * | 2002-03-07 | 2003-09-16 | Biocompatibles Uk Limited | Drug carriers comprising amphiphilic block copolymers |
-
2004
- 2004-12-20 EP EP04806454A patent/EP1701704A2/en not_active Withdrawn
- 2004-12-20 US US10/596,876 patent/US8974823B2/en not_active Expired - Fee Related
- 2004-12-20 BR BRPI0418330-4A patent/BRPI0418330A/pt not_active IP Right Cessation
- 2004-12-20 CA CA002548376A patent/CA2548376A1/en not_active Abandoned
- 2004-12-20 JP JP2006546397A patent/JP2007517016A/ja not_active Abandoned
- 2004-12-20 WO PCT/IB2004/004287 patent/WO2005065657A2/en not_active Ceased
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009510138A (ja) * | 2005-10-04 | 2009-03-12 | バイエル・ヘルスケア・アクチェンゲゼルシャフト | 経口投与でき、かつ活性成分の迅速な放出を有する固形医薬投与形態 |
| JP2014500869A (ja) * | 2010-11-09 | 2014-01-16 | エフ.ホフマン−ラ ロシュ アーゲー | Hcv感染症を処置するための医薬組成物 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005065657A3 (en) | 2006-06-22 |
| BRPI0418330A (pt) | 2007-05-02 |
| CA2548376A1 (en) | 2005-07-21 |
| US20070141143A1 (en) | 2007-06-21 |
| US8974823B2 (en) | 2015-03-10 |
| WO2005065657A2 (en) | 2005-07-21 |
| EP1701704A2 (en) | 2006-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8974823B2 (en) | Solid compositions of low-solubility drugs and poloxamers | |
| Huang et al. | Effects of the preparation process on the properties of amorphous solid dispersions | |
| JP4065640B2 (ja) | 医薬用固体分散物 | |
| EP1653928B1 (en) | Spray drying processes for forming solid amorphous dispersions of drugs and polymers | |
| KR100664822B1 (ko) | 변형된 분무-건조 장치를 이용한 균질한 분무-건조된 고체비결정성 약물 분산액의 제조 방법 | |
| JP2984661B2 (ja) | 噴霧乾燥固体分散系を含む組成物 | |
| US8491933B2 (en) | Pharmaceutical compositions of semi-ordered drugs and polymers | |
| KR20150082203A (ko) | 엔잘루타마이드 제제 | |
| ZA200600853B (en) | Spray drying processes for forming solid amorphous dispersions of drugs and polymers | |
| EP1701703B1 (en) | Stabilized pharmaceutical solid compositions of low-solubility drugs, poloxamers and stabilizing polymers | |
| CN105722392B (zh) | 非核苷逆转录酶抑制剂的组合物 | |
| MXPA06007625A (en) | Solid compositions of low-solubility drugs and poloxamers | |
| HK40119846A (en) | Oral dosage forms of elraglusib | |
| MXPA00001463A (en) | Pharmaceutical solid dispersions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20071220 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20071220 |
|
| A762 | Written abandonment of application |
Free format text: JAPANESE INTERMEDIATE CODE: A762 Effective date: 20080502 |